AAI Brief on Pharma Pay-For-Delay Highlighted by Law360

Law360’s March 6 article “AARP, Consumer Groups Back Calif. Pay-For-Delay Ban” cited AAI’s amicus brief in AAM v. Becerra.

AAI’s Ninth Circuit brief, which was joined by Consumer Reports and Public Citizen, explained the severity of the harm caused by payments to exclude generic competition, and why AB 824 is an appropriate and beneficial outgrowth of the logic underlying the Supreme Court’s watershed decision in FTC v. Actavis and the California Supreme Court’s decision in In re Cipro Cases I & II.